Covidien’s Venefit™ targeted endovenous segmental ablation therapy using the ClosureFast™ catheter and generator is a minimally invasive therapy that is used to treat chronic venous insufficiency (CVI)—a condition that is often preceded by varicose veins. Steve Elias, MD FACS FACPh delivered the keynote speech at a luncheon symposium and shared the clinical benefits of ClosureFast with all of the attendees at the Japanese meeting.
Following the Japanese Society of Phlebology meeting, Dr. Elias held a Train the Trainer event in which eight key Japanese vascular surgeons were taught the Venefit™ procedure technique by Dr. Elias. This treatment utilizes radiofrequency (RF) energy to uniformly distribute heat to the diseased vein walls in the legs of a patient with varicose veins. The diseased veins are sealed by the heat so that blood will flow through healthy veins instead, thus reducing the pain and appearance of varicose veins. An expert in vein disease and technology, Dr. Elias answered questions and concerns from physicians and industry leaders present regarding the modern management of vein disease.
Dr. Steve Elias (MD FACS FACPh) Director, Center for Vein Disease and the Wound Care Center of Englewood Hospital, NJ, was named by VEIN Magazine as one of the 25 most influential professionals in vein care worldwide and Voted "Best Doctor" for 3 consecutive years by New York Magazine.